Dyslipidaemia in HIV-1-infected patients receiving protease inhibitors after initial treatment with first-line-based non-nucleoside reverse transcriptase inhibitors: a cross-sectional study

समान संसाधन

• First-line antiretroviral therapy and dyslipidemia in people living with HIV-1 in Cameroon: a cross-sectional study
  द्वारा: Pefura Yone, Eric Walter, और अन्य
  प्रकाशित: (2011)
• First-line antiretroviral therapy and dyslipidemia in people living with HIV-1 in Cameroon: a cross-sectional study
  द्वारा: Kengne André, और अन्य
  प्रकाशित: (2011-09-01)
• Metabolic Abnormalities Associated with the Use of Protease Inhibitors and Non-nucleoside Reverse Transcriptase Inhibitors
  द्वारा: Rao, Madhu N., और अन्य
  प्रकाशित: (2006)
• Use of Protease Inhibitors and Non-Nucleoside Reverse Transcriptase Inhibitors Among Medicaid Beneficiaries With AIDS
  द्वारा: Sambamoorthi, Usha, और अन्य
  प्रकाशित: (2001)
• Sociodemographic Factors Predict Early Discontinuation of HIV Non-Nucleoside Reverse Transcriptase Inhibitors and Protease Inhibitors
  द्वारा: Asad, Shaheena, और अन्य
  प्रकाशित: (2008)